Company Focus

CSL Limited.

Latest CSL Limited. News

First hemophilia B patients treated with Hemgenix in Europe
Biotechnology
Global biotechnology firm CSL Behring has announced that two patients with hemophilia B have been treated with the gene therapy Hemgenix (etranacogene dezaparvovec).   5 July 2024


Insights

Company Spotlight

Latest News & Features of interest to CSL Limited.

Latest Relevant Ones To Watch News

California, USA-based biotech Nektar Therapeutics’ shares closed up more than 8% at $1.33 yesterday after it announced the sale of its only manufacturing facility.   5 November 2024

More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search